HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaoxing Xiong Selected Research

N-methylisoindigotin

1/2021Meisoindigo inhibits cellular proliferation via down-regulation of the PI3K/Akt pathway and induces cellular apoptosis in glioblastoma U87 cells.
1/2019Meisoindigo Protects Against Focal Cerebral Ischemia-Reperfusion Injury by Inhibiting NLRP3 Inflammasome Activation and Regulating Microglia/Macrophage Polarization via TLR4/NF-κB Signaling Pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaoxing Xiong Research Topics

Disease

26Stroke (Strokes)
10/2021 - 07/2011
19Neoplasms (Cancer)
10/2022 - 02/2015
19Inflammation (Inflammations)
10/2021 - 07/2011
16Brain Ischemia (Cerebral Ischemia)
05/2021 - 01/2011
12Ischemic Stroke
01/2022 - 12/2018
12Infarction (Infarctions)
01/2019 - 07/2011
10Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2021 - 07/2011
9Reperfusion Injury
10/2020 - 01/2016
9Brain Injuries (Brain Injury)
01/2019 - 07/2011
5Glioblastoma (Glioblastoma Multiforme)
01/2021 - 01/2017
4Glioma (Gliomas)
10/2022 - 01/2017
4Brain Edema (Cerebral Edema)
05/2021 - 05/2014
4Ischemia
01/2020 - 04/2015
3Atherosclerosis
01/2022 - 01/2016
3Neuroinflammatory Diseases
01/2021 - 01/2016
3Brain Infarction
10/2020 - 02/2015
2Carcinogenesis
01/2022 - 01/2021
2Pathologic Processes
01/2020 - 12/2015
2Neoplasm Metastasis (Metastasis)
01/2020 - 01/2016
2Cerebral Infarction
05/2016 - 01/2016
2Infections
09/2015 - 03/2013
2Brain Neoplasms (Brain Tumor)
02/2015 - 03/2013
1Hypoxia (Hypoxemia)
01/2022
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
10/2021
1Porcine Reproductive and Respiratory Syndrome (PRRS)
05/2021
1Ventricular Fibrillation
01/2021

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2013
7CytokinesIBA
05/2021 - 07/2011
5Pharmaceutical PreparationsIBA
10/2022 - 05/2016
5Oxygen (Dioxygen)IBA
10/2021 - 05/2014
5Reactive Oxygen Species (Oxygen Radicals)IBA
10/2021 - 05/2016
4T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2022 - 01/2017
4Interleukin-4 (Interleukin 4)IBA
01/2022 - 07/2011
4InflammasomesIBA
05/2021 - 01/2016
4Messenger RNA (mRNA)IBA
01/2021 - 03/2013
3Interleukin-6 (Interleukin 6)IBA
01/2022 - 03/2013
3Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2020
3Immune Checkpoint InhibitorsIBA
01/2022 - 01/2017
3ChemokinesIBA
01/2022 - 07/2012
3Glucose (Dextrose)FDA LinkGeneric
10/2021 - 01/2020
3Neuroprotective AgentsIBA
01/2021 - 12/2018
3salicylhydroxamic acid (SHAM)IBA
01/2021 - 03/2013
3HMGB1 Protein (HMG1)IBA
01/2019 - 01/2013
2Interleukin-10 (Interleukin 10)IBA
01/2022 - 01/2016
2InterleukinsIBA
01/2022 - 08/2015
2Peptides (Polypeptides)IBA
10/2021 - 01/2016
2EnzymesIBA
10/2021 - 01/2019
2AntioxidantsIBA
10/2021 - 10/2018
2N-methylisoindigotinIBA
01/2021 - 01/2019
2Nitric Oxide (Nitrogen Monoxide)FDA Link
09/2020 - 01/2020
2Monomeric GTP-Binding ProteinsIBA
08/2020 - 09/2019
2Free RadicalsIBA
01/2020 - 04/2015
2TRPC6 Cation ChannelIBA
01/2020 - 01/2020
2MicroRNAs (MicroRNA)IBA
01/2019 - 02/2015
2Chimeric Antigen ReceptorsIBA
01/2018 - 01/2017
2Peroxidase (Myeloperoxidase)IBA
01/2016 - 07/2011
2triphenyltetrazoliumIBA
08/2015 - 07/2011
2AntagomirsIBA
02/2015 - 02/2015
1Antineoplastic Agents (Antineoplastics)IBA
10/2022
1Metal-Organic FrameworksIBA
02/2022
1PolymersIBA
02/2022
1Doxorubicin (Adriamycin)FDA LinkGeneric
02/2022
1Cisplatin (Platino)FDA LinkGeneric
02/2022
1Therapeutic UsesIBA
02/2022
1Interleukin-9 (Interleukin 9)IBA
01/2022
1Interleukin-12 (IL 12)IBA
01/2022
1Blood Glucose (Blood Sugar)IBA
01/2022
1Interleukin-5 (Interleukin 5)IBA
01/2022
1Interleukin-1 (Interleukin 1)IBA
01/2022
1Interleukin-33IBA
01/2022
1Interleukin-23 (Interleukin 23)IBA
01/2022
1Interleukin-8 (Interleukin 8)IBA
01/2022
1Interleukin-16 (Interleukin 16)IBA
01/2022
1Interleukin-13IBA
01/2022
1Interleukin-17 (Interleukin 17)IBA
01/2022
1Interleukin-15 (Interleukin 15)IBA
01/2022
1Interleukin-22 (IL-22)IBA
01/2022
1interleukin-21 (interleukin 21)IBA
01/2022
1Collagen Type V (Type V Collagen)IBA
01/2022
1Interleukin-2 (IL2)IBA
01/2022
1CollagenIBA
01/2022
1Interleukin-18 (Interleukin 18)IBA
01/2022
1Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2022
1pinacolIBA
10/2021
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
10/2021
1OligosaccharidesIBA
10/2021
1EstersIBA
10/2021
1CyclodextrinsIBA
10/2021
1benzeneboronic acidIBA
10/2021
1tempolIBA
10/2021
1NF-kappa B (NF-kB)IBA
05/2021
1Mitogen-Activated Protein KinasesIBA
05/2021
1Pattern Recognition ReceptorsIBA
05/2021

Therapy/Procedure

19Therapeutics
02/2022 - 03/2012
2Drug Therapy (Chemotherapy)
01/2022 - 10/2018
2Immunotherapy
01/2020 - 01/2017
2Sutures (Suture)
02/2013 - 07/2012
1Precision Medicine
10/2022
1Photothermal Therapy
10/2022
1Combination Drug Therapy (Combination Chemotherapy)
02/2022